Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 14,750	$ 10,736
Cost of revenues	8,203	6,583
Gross profit	6,547	4,153
Operating expenses:
General and administrative	6,050	8,866
Sales and marketing	3,896	3,353
Research and development	2,347	2,890
Total operating expenses	12,293	15,109
Operating loss	(5,746)	(10,956)
Other income (expense):
Interest expense, net	(161)	(2,812)
Common stock warrant liability adjustment	9,179	1,912
Other (expense) income, net	2	(11)
Total other (expense) income, net	9,020	(911)
Income (loss) before income tax provision	3,274	(11,867)
Income tax provision	0	0
Net income (loss) and comprehensive income (loss)	3,274	(11,867)
Accretion on convertible preferred stock	(1,328)	(653)
Net income (loss) allocated to participating securities	(661)	0
Net Income (Loss) Available to Common Stockholders, Basic, Total	$ 1,285	$ (12,520)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ 0.15	$ (1.54)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.51)	$ (1.54)
Weighted-average common shares outstanding, basic (in shares)	8,740,059	8,110,387
Weighted-average number of shares outstanding, diluted (in shares)	9,617,825	8,110,387